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Membrane proteins (MPs) are macromolecular structures involved in a number of 
diverse cellular functions, from energy conversion and signal transduction, to ion 
transport across the phospholipid bilayer.  MPs represent a large number of drug targets 
and due to their localization within a lipid bilayer, their over-expression, purification and 
crystallization embody significant hurdles to three-dimensional structure determination, 
which is essential for rational drug design.  The difficulties associated with MP structure 
determination relate to why the availability of their three-dimensional (3D) structures is 
severely underrepresented in the Protein Data Bank (PDB) when compared to that of 
soluble proteins.  Structural determination of membrane proteins answers critical 
questions related to their structure-function relationship and represents an intensely 
studied field in biology. 
Human leukotriene C4 synthase (hLTC4S) is an integral MP involved in the 5-
lipoxygenase pathway. hLTC4S catalyzes the conjugation of leukotriene A4 (LTA4) and 
reduced glutathione (GSH) to produce product leukotriene C4 (LTC4), which along with 
its metabolites leukotriene D4 (LTD4) and leukotriene E4 (LTE4) represent the cysteinyl 
leukotrienes that mediate pro-inflammatory activities such as asthma and 
bronchoconstriction.  Alongside wild-type (WT) enzyme, mutant construct R104A was 
studied, an amino acid side chain implicated in substrate binding.  Under the mentorship 
of Dr. Ingeborg Schmidt-Krey and collaboration with graduate student Matthew C. 
Johnson, I have been able to reproduce the over-expression, purification and two-
dimensional (2D) crystallization of hLTC4S based on previously published protocols 
(Schmidt-Krey et al., 2004 and Zhao et al., 2010), with slight modifications.  Using these 
methods, preliminary 2D crystals of the R104A mutant enzyme have been grown, 
representing progress in the purification of hLTC4S for two-dimensional crystallization 
 xiv 
by electron crystallography.  2D crystallization trials investigating the optimal conditions 
to grow large, well-ordered 2D crystals of the mutant enzyme via dialysis were 
investigated, primarily by varying the time in dialysis and lipid-to-protein ratio (LPR), 
with a focus on lower LPRs.  In total, this work displays an adjusted protocol for the 
purification of hLTC4S and preliminary examinations of conditions for 2D crystallization 








1. OVER-EXPRESSION OF HUMAN LEUKOTRIENE C4 
SYNTHASE IN SCHIZOSACCHAROMYCES POMBE 
1.1 BACKGROUND AND SIGNIFICANCE 
Membrane protein overview 
Membrane proteins (MPs) are specialized macromolecules localized within the lipid 
bilayer that oftentimes aid in the communication between both sides of the membranes 
environment.  MPs are involved in numerous cellular functions, including signal 
transduction, small molecule translocation, and energy conversion (Krebs et al., 2003; 
Appel et al., 2009; Morosinotto et al., 2006) and encode for up to 30% of proteins of the 
eukaryotic genome.  With their in-depth involvement in cellular processes and large 
representation in the human genome, MP malfunction can play a critical role in several 
disease pathologies and represent ~60% of drug targets (Drews, 2000 and Cooper, 2004 
Lappano and Maggiolini, 2011).  Despite their importance in cell physiology, available 
crystal structures of MPs are severely underrepresented when compared to their soluble 
counterparts, with less than 0.5% of the total structures deposited in the Protein Data 
Bank (PDB) representative of MPs (Kühlbrandt, 2012).  High-resolution structure 
determination of MPs is critical for rational drug design and to better understand the basis 
and mechanism of protein-lipid and protein-protein interactions within the phospholipid 
bilayer.  In order to successfully solve the 3D structure of any MP, several technical 
difficulties must be overcome, including their over-expression, purification, and 
crystallization (Renault et al., 2006). 
 
Difficulties encountered during membrane protein over-expression 
 The extensive and comprehensive functional and structural study of a MP requires 
large amounts of homogenous, pure and biologically active protein.  The first hurdle that 
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must be overcome is their over-expression within an expression system.  Relying on 
naturally expressed protein is problematic since most MPs are expressed in vivo at 
insufficiently low concentrations (Grishammer and Tate, 1995, Hays et al., 2010).  An 
example of an MP successfully over-expressed in its native tissue is bacteriorhodopsin, 
which is the only protein present in the Halobacterium halobium purple membrane 
(Oesterhelt and Stoeckenius, 1974).  Naturally expressed proteins cannot be manipulated 
by genetic modifications such as affinity tagging, to assist in detection and purification, 
and point mutations, to study effects of changes in amino acid sequence on tertiary 
structure.  Thus, researchers need to rely on the homologous or heterologous over-
expression of recombinant membrane proteins, often within a prokaryotic bacterial or 
eukaryotic yeast expression system such as Escherichia coli (E. coli) or Saccharomyces 
cerevisiae (S. cerevisiae), respectively (Wagner et al., 2006).  
MP over-expression is organized into two parts: first, the transcription and 
translation of genetic material, and second, membrane insertion and folding (Kozak, 
1991, Kozak 1992, Grishammer and Tate, 1995).  There are factors that influence the 
expression of membrane proteins.  A study of 1092 predicted soluble and MPs expressed 
in S. cerevisiae showed that smaller proteins (less than 60 kDa), with a lower number of 
transmembrane segments (less that 5 transmembrane segments), and a high percentage of 
hydrophobic residues found in transmembrane segments (more than 70%) were highly 
expressed (White et al., 2007).  On the other hand, another study of 601 inner membrane 
proteins expressed in E. coli showed conflicting data: expression levels are not related to 
superficial sequence characteristics such as codon usage protein size, hydrophobicity and 
the number of transmembrane helices, leading to the conclusion that expression levels 
cannot be easily predicted (Daley et al., 2005). 
 Inducible expression is preferred to constitutive expression as it allows regulated 
control of promoter activity, which in turn controls levels of recombinant protein 
expression (Abeyrathne et al., 2010).  MP over-expression is often toxic to the cell, 
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leading to the production of inactive protein or insoluble aggregates (Miroux and Walker, 
1996) and decreasing host-cell sustainability.  Also, high expression levels may apply 
metabolic expenditures on the host cell, such as overloading the Sec translocon 
machinery that may cause a decrease in growth rates (Kumar and Singh, 2006 and 
Wagner et al., 2007). 
 Prokaryotic and eukaryotic gene expression differs in many ways, which should 
be considered to optimize functional protein production.  In this work hLTC4S was 
expressed in the fission yeast Schizosaccharomyces pombe.  A major difference between 
prokaryotic and eukaryotic MP expression is where over-expression will occur.  In 
bacteria, over-expression occurs in the cytoplasmic membrane whereas in eukaryotes it 
occurs in the endoplasmic reticulum.  Eukaryotic expression systems may be preferred 
over prokaryotic: polypeptide elongation and protein folding rates are greater in 
prokaryotes, leading to the possibility of mistargeting and misfolding during expression 
(Wagner et al., 2006).  Upon insertion into the membrane, the polypeptide must undergo 
proper folding in order to obtain its final and enzymatically active 3D conformation.  The 
choice between a eukaryotic or prokaryotic expression host is critical, as certain 
membrane proteins require specific phospholipid composition for activity (Grishammer 
and Tate, 1995).  For example, the sodium- and chloride- dependent aminobutyric acid 
(GABA) transporter (Shouffani and Kanner, 1990) and serotonin transporter (SERT) 
(Tate, 2001) both require cholesterol for activity, and so should be expressed in a 
eukaryotic expression system and not in E. coli which does not contain cholesterol in its 
native cell membrane.  However, the addition of necessary lipids during and/or after 
purification can restore functionality, as was seen for LacY where translocation across 
the E. coli inner membrane was restored upon addition of phosphatidylethanolamine 
(PE), a non-protein molecular chaperone (Bogdanov et al., 1999).  Similarly, the 
expression of MPs that require post-translational modifications for activity, such as 
glycosylation or phosphorylation, should be handled in eukaryotic expression hosts 
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because bacterial cells are unable to modify proteins after translation (Abeyrathne et al., 
2010). 
When considering eukaryotic expression systems, yeasts are cheaper and easier to 
care for when compared to other eukaryotic expression systems like insect and 
mammalian cells (Abeyrathne et al., 2010).  The most commonly used species of yeast 
include Saccharomyces cerevisiae (S. cerevisiae), Schizosaccharomyces pombe (S. 
pombe), and Pischia pastoris (P. pastoris).  As mentioned earlier, hLTC4S was expressed 
in S. pombe (Schmidt-Krey et al., 2004).  Although budding yeast S. cerevisiae is more 
frequently used as a host for protein expression investigations, S. pombe has been 
employed for the successful over-expression of several integral MPs, including human 
glucose transporters GLUT1, GLUT2, and GLUT 3 (Yang et al., 2009) and human 
chemokine receptor CCR-5 (Chen et al., 2011).  In another study, it was shown that 
fission yeast S. pombe expressed more protein than S. cerevisiae: Sander et al. found that 
the human D2S dopamine receptor could be expressed at greater concentrations in S. 
pombe (Sander et al., 1994).  Furthermore, S. pombe’s transcription initiation is similar to 
that of higher eukaryotes (Bharathi et al., 1997).  A notable disadvantage of yeast 
expression is the presence of endogenous proteases in vacuoles that can affect protein 
production (Jones, 2002).  Several MP structures have been determined using yeast 
expression systems: single particle analysis and 2D crystallization of voltage-sensitive 
K+- channel (Parcej and Eckhardt-Strelau, 2002), x-ray crystallography of monoamine 
oxidase-B (Binda et al., 2003), and x-ray crystallography of yeast aquaporin Aqy1 
(Fischer et al., 2009). 
If the quality of expressed MPs is sub-par, i.e. heterogeneous due to proteolytic 
cleavage or posttranslational modifications, it is important to address these issues as they 
will affect crystallization trials negatively.  For heterogeneity due to proteolysis, flexible 
domains of the enzyme should be removed, which can be recognized by first identifying 
the proteolytically stable core by mild proteolytic treatment in conjunction with mass 
 5 
spectrometry.  A refined DNA construct was built for the E. coli glycerol-3-phosphate 
transporter, GlpT (Auer et al., 2001) white full-length KcsA K+-channel was treated with 
proteases trypsin, chymotrypsin, and subtilisin to reveal the proteolytically resistant core 
used for crystallization trials (Cohen and Chait, 2001).  Upon successful over-expression, 
proper insertion and folding should be confirmed by testing the activity of the protein.  
Ideally, the host cell should not express any endogenous proteins with similar activity as 
the MP of interest and any naturally expressed protein should not interfere with the 
activity measurement of the MP of interest (Abeyrathne et al., 2010).  
 
Membrane Protein of Interest: Leukotriene C4 Synthase 
 
 Leukotriene C4 Synthase (LTC4S) is an 18 kDa, 150 amino acid, integral MP 
localized to the outer membrane of mast cells, eosinophils, basophils, endothelial cells 
and platelets (Christmas et al., 2002 and Strid et al., 2009).  LTC4S is encoded by LTC4S, 
a 2.5 kb gene with chromosomal location on 5q35 (Penrose et al., 1996).  LTC4S is a 
lyase that catalyzes the conjugation of leukotriene A4 (LTA4) and reduced glutathione 
(GSH) to yield leukotriene C4 (LTC4) (Figure 1.1) (Yoshimoto et al., 1988, Nicholson et 
al., 1993).  LTC4S activity is amplified by Mg+2 and decreased by Co+2 ions (Nicholson 




Figure 1.1.  Schematic of LTC4S enzymatic reaction.  LTC4S is responsible for 
conjugating substrates leukotriene A4 (top left) and reduced glutathione (bottom left) to 
form leukotriene C4 (right) in a non-reversible enzymatic reaction (Molina et al., 2007). 
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LTC4 and its metabolites LTD4 and LTE4 are the cysteinyl leukotrienes produced 
from the conversion of arachidonic acid in a multistep enzyme pathway called the 5-
lipoxygenase pathway.  The 5-lipoxygenase pathway mediates asthmatic airway 
inflammation and bronchoconstriction and is active in leukocytes like neutrophils, mast 
cells and monocytes (Duroudier et al., 2009).  As seen in Figure 1.2 (Soberman and 
Christmas, 2003), this enzymatic reaction occurs in several distinct steps: leukocytes are 
activated causing a rise in free calcium which induces the translocation of calcium-
dependent cytoplasmic phospholipase A2 (cPLA2) to the nuclear envelope where it 
releases arachidonic acid (AA) (Glover et al., 1995).  Next, 5- lipoxygenase (5-LO) is 
phosphorylated by MAP kinase kinase (MAPKK) and translocates through the nuclear 
pore, associates with 5-lipoxygenase activating protein (FLAP) (Rouzer and Kargman, 
1988, Kargman et al., 1992).  FLAP then presents AA to 5-LO, the rate-limiting enzyme, 
which then oxygenates AA to form the unstable intermediate 5- 
hydroperoxyeicosatetraenoic acid (5-HPETE).  5-HPETE is either hydrolysed to form 5-
hydroxyeicosatetraenoic acid (5-HETE) or converted to the unstable epoxide, leukotriene 
A4 (LTA4), by dehydration (Rouzer et al., 1986).  LTA4 can either form LTB4 via LTA4 
hydrolase (Radmark et al., 1988), or form LTC4 via LTC4 synthase (LTC4S).  LTC4 is 
then transported out of the cell by multidrug resistance protein 1 (MPR1) (Lam et al., 
1989, Jedlitschky et al., 1994, Loe et al., 1996), where it is hydrolyzed by peptidases to 
form metabolites LTD4 and LTE4, which bind G protein-coupled receptors (GPCRs) 
CysLT1 or CysLT2, causing smooth muscle constriction and inflammation (Lewis et al., 
1990, Samuelsson et al., 1987, Taylor et al., 1989).  The CysLT1 receptor has higher 
binding affinity for LTD4, while CysLT2 receptor has high binding affinity for LTC4 and 
LTD4 (Lynch et al., 1999, Hui et al., 2001). 
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Figure 1.2.  The 5-lipoxygenase pathway for leukotriene biosynthesis.  This diagram 
illustrates the multi-step breakdown of arachadonic acid (AA) to form the final products 
of the 5-lipoxygenase pathway, LTC4, and its metabolites, LTD4 and LTE4 (Soberman 




 LTC4S belongs to the family of Membrane-Associated Proteins in Eicosanoid and 
Glutathione metabolism (MAPEG) proteins, which include divergent proteins 5-
lipoxygenase-activating protein (FLAP), microsomal glutathione S-transferase 1, 2, 3 
(MGST1, MGST2, MGST3), and prostaglandin E synthase (PTGES) which share 31%, 
18%, 44%, 27% and 14% amino acid sequence similarity, respectively (Jakobsson et al., 
1999) (Figure 1.3).  MK-886, a FLAP inhibitor, which binds a shared and related 
arachadonic acid binding domain in LTC4S, also inhibits LTC4S activity (Vickers et al., 
1992 and Abramovitz et al., 1993).  Drugs developed as CysLT1 receptor antagonists 
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include Pranlukast (Onon®; Ono Pharmaceutical Co, Ltd, Osaka City, Tokyo, Japan), 
Montelukast Singulair®; Merck & Co, Inc, Whitehouse Station, New Jersey, USA) and 
Zafirlukast (Accoalte®; AstraZeneca Pharmaceuticals LP, Wilmington, Delaware, USA) 
and 5-lipoxygeanse inhibitor Zileuton (Zyflo®; Cornerstone Therapeutics Inc, Cary, 
North Carolina, USA) (Tantisira and Drazen, 2009 and Duroudier et al., 2009) but none 
have yet been established that directly inhibit LTC4S activity.  This is important because 
LTC4S represents the only commited enzyme of the 5-lipoxygenase pathway, ensuring 
the production of the cysteinyl leukotrienes that cause inflammation (Lam, 2003).  
Although the x-ray crystal structure of LTC4S has been determined in 2007 by two 
separate groups (Ago et al., 2007 and Molina et al., 2007), which is discussed in further 
details in Chapter 3, we are interested in solving the structure by electron crystallography, 





Figure 1.3.  Sequence alignment of MAPEG family proteins.  Sequence alignment of all 
proteins within the membrane-associated proteins of eicosanoid and glutathione 
metabolism (MAPEG) family: leukotriene C4 synthase (LTC4S), 5-lipoxygenase 
activating protein (FLAP), microsomal glutathione S-transferase 1, 2, & 3 (MGST1, 
MGST2, & MGST3), and membrane-associated prostaglandin E synthase-1 (mPGES1).  
Conserved residues are colored red, asterisks (*) denote residues that interact with GSH, 
and plus (+) signs denote residues that form the LTA4 binding site which will be 




Arg104s role in substrate activation 
 An in-depth description of previous works performed of hLTC4S is summarized 
in Chapter 3.  In 2007 the x-ray crystal structure of substrate-bound LTC4S was solved by 
two groups (Ago et al., 2007, Molina et al., 2007) revealing important details about 
glutathione (GSH) binding.  In particular, the GSH binding site is located between 
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adjacent monomers, in a U-shaped cavity close to the cytosolic side of the enzyme.  GSH 
interacts directly with nine residues: Arg51, Tyr97, Arg104, Tyr93, Asn55, Glu58, and 
Tyr59 from one monomer and Arg30 and Gln53 from a second neighboring monomer 
(Figure 1.4a and 1.4b).  Of these nine amino acid residues, R104 is of particular interest 
in this study because it was observed to interact with the thiol group of GSH (Ago et al., 
2007, Molina et al., 2007).  It is predicted that R104 abstracts the proton off the thiol 
group, producing a thiolate anion and activating GSH (GS-).  The activated GS- can then 
attach the C6 position of LTA4, forming a thioether bond.  The resulting C5 hydroxyl 
anion is protonated by R31 of monomer A, forming the final product LTC4 (Ago et al., 
2007 and Saino et al., 2011).  This proposed mechanism can be seen schematically drawn 
in Figure 1.4c.  Another graduate student of the Schmidt-Krey lab, Matthew Johnson, is 






























Figure 1.4.  Crystal structure of GSH-bound LTC4S.  GSH binding is localized within a 
cavity between adjacent monomers of LTC4S.  a) Nine amino acid residues interact 
directly with GSH.  Electron density maps of side chains (blue mesh) and GSH (red 
mesh) are shown, superimposed on stick models of the amino acid side chains of 
neighboring monomers (Green and silver, respectively).  b) electrostatic interactions 
between GSH and side chains of neighboring monomers, denoted [A] and [C].  
Specifically, this includes helices IIa (light blue), III (yellow), and IVa (pink) from 
monomer C and helices I (brown) and IIa (silver) of monomer A.  Arg104 of monomer C, 
the residue of interest in this study, is shown interacting with the thiol group of GSH 




 Based on the structural information obtained from the crystal structure of LTC4S, 
it is of interest to see what deviations from structure and catalytic mechanism are 






in substrate binding.  When R104 was mutated to an alanine (R104A) the enzymes 
activity was nearly abolished (Saino et al., 2011), which lends further support to the 
importance of this residue in catalytic mechanism.  It is of interest to over-express, purify 
and obtain 2D crystals of mutant R104A, alongside wild-type (WT) LTC4S, to answer 
questions related to structure-function changes that may be observed by electron 
crystallography.  
 
Molecular cloning of hLTC4S and transformation in 
Schizosaccharomyces pombe  
 Expression cloning of the cDNA for human leukotriene C4 synthase (hLTC4S) 
was performed by Lam et al. (1994).  Transfection of KG-1 cDNA expression library in 
COS-8 cells was performed, upon which a fluorescence- linked immunoassay for 
enzymatic product LTC4 after addition of substrate LTA4, was used to screen for hLTC4S 
activity.  Individual clones with maximal hLTC4S activity contained a 694-bp cDNA 
insert with an open reading frame encoding a 16.5 kDa protein of 150 amino acids with a 
pI of 11.05 (Figure 1.5 (Lam et al., 1994).  By polymerase chain reaction (PCR), an NdeI 
restriction site was created at the ATG start codon and His6-tag created at the C-terminus, 
of the hLTC4S cDNA using a sense primer (5’GGTCATATGAAGGACGAGGTAGCT-
3’) and an antisense primer (5’-CTTGAATTCAGTGATGGTGATGGTGATGGGCC 
CACGGCAGCAGCGT-3’).  The use of C-terminal tags is preferred because it helps 
ensure that the purified protein is the full-length construct, free of truncation or 
degradation (Hays, 2010).  The fragmented sequence was amplified, subcloned into a 
pCR-Script vector (Stratagene, La Jolla, CA), and confirmed by DNA sequencing.  The 
NdeI and SmaI fragment was subcloned into a pESP-3 vector (Stratagene) and treated 
with NdeI and SmaI digestion enzymes to remove the hLTC4S gene from pESP-3.  
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Finally, the resultant plasmid was transfected into expression host Schizosaccharomyces 
pombe, genotype h-leu 1-32 (Schmidt-Krey et al., 2004). 
 
 
Figure 1.5.  hLTC4S DNA and amino acid sequence.  Predicted transmembrane helices 
are boxed, predicted protein kinase C phosphorylation sites are underlined, and potential 
N-linked glycosylation site noted by an asterisk.  Numbers represent nucleotide and 




Induced over-expression of hLTC4S using NMT1 promoter 
 According to Schmidt-Krey et al. (2004) Schizosaccharomyces pombe (S. pombe) 
was selected as the host expression system for this study.  As mentioned above, over-
expression in yeast has many benefits in general (Andre et al., 2006 and Wagner et al., 
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2006), and specifically in S. pombe (Yang et al., 2009, Chen et al., 2011, and Sander et 
al., 1994).  The genome of this popular model system was sequenced and annotated in 
2002, revealing detailed information about the number of protein-coding genes, 
centromere length, and identification of conserved genes for eukaryotic cell organization 
(Wood et al., 2002).  S. pombe is considered to be more closely related to higher 
eukaryotes than S. cerevisiae in several aspects, such as cell cycle regulation and 
chromosomal organization (Kaufer et al., 1985).  Several vectors have been developed 
and are now available for regulated or constitutive expression of heterologous or 
homologous genes specifically for S. pombe, which no longer rely on plasmids derived 
from S. cerevisiae that work at low efficiency in the fission yeast (Siam et al., 2004).  
Thus, the use of S. pombe as an expression host for mammalian proteins is more likely to 
be comparable to its native and biologically functional counterpart (Yang et al., 2009). 
 The nmt1+ (no message in thiamine) promoter is one of the most frequently used 
regulatable promoters for S. pombe protein expression studies.  It was the first promoter 
to be cloned and characterized in S. pombe (Maundrell, 1990).  As the name implies, the 
promoter is tightly repressed in the presence of 0.5 – 15 µM thiamine (vitamin B1) in the 
growth media (Yang et al., 2009).  Maximum induction is achieved when cells are grown 
in thiamine-free media for 16 – 20 hours (Forsburg, 2003).  It was found that over-
expression was achieved when yeast extract + supplements (YES) media was incubated 
until an optical density measure at 600 nm wavelength, or OD600, of 0.8 – 1.0 was 
reached (Yang et al., 2009). An OD600 of 1 equals ~ 1.5 x 107 cells per mL, but it should 
be noted that OD600 is a measure of cell mass, not cell number (Forsburg, 2003).  YES is 
the rich medium used for general growth, which contains thiamine for promoter 
repression; induction necessitates the use of Edinburgh minimal medium (EMM) which 
is the minimal medium used for regulative induction and mating suppression and contains 
no thiamine (Forsburg, 2003).  S. pombe generation time ranges from 2 – 5 hours at 
 15 
permissive temperatures of 17 – 36°C, with a preferred temperature of 32°C (Siam et al., 
2004). 
 
1.2 MATERIALS AND METHODS 
Materials 
 Human LTC4S (hLTC4S), subcloned into a pESP-3 vector and transfected into 
Schizosaccharomyces pombe, was a generous gift from K. Frank Austen, Harvard 
Medical School, Massachusetts (Lam et al., 1994 and Schmidt-Krey et al., 2004). 
 Yeast extract + supplement (YES) and Edinburg minimal media (EMM) were 
both purchased from MP Biomedicals®.  Thiamine hydrochloride (vitamin B1 
hydrochloride) was purchased from Sigma-Aldrich®. 
 
Methods 
Cell culture and expression 
 Cell culture and expression was achieved according to Schmidt-Krey et al. 
(2004).  Cell culture media was prepared according to the manufacturer.  35 g per L of 
YES media was prepared and autoclaved at 121°C.  Upon cooling to room temperature, 
filter-sterilized thiamine hydrochloride was added to a final concentration of 5 µM to 
maintain selection for the plasmid containing hLTC4S.  hLTC4S 50% glycerol stocks, 
stored at -80°C, were transferred into the YES media.  The thiamine-inoculated yeast cell 
culture was incubated for 18 hours, at 250 rpm and 28°C, until an OD600 of 0.8 – 1.0 was 
obtained.  Cells were harvested by centrifugation at 5000 x g for 3 minutes at room 
temperature, until all media was spent and the supernatant discarded.  The yeast cell 
pellet was washed by resuspension with sterile water followed by centrifugation at 5000 
x g for 3 minutes at room temperature and the supernatant discarded.  Expression was 
induced by resuspending the final yeast pellet in EMM broth (32 g per L in ddH2O) and 
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autoclaved at 121°C and cooled to room temperature.  The yeast cell culture was finally 
grown at 30°C at 200 rpm for 16 - 20 hours.  After cell culture and expression, the yeast 
culture was harvested by centrifugation at 5000 x g for 3 minutes at room temperature 
and the supernatant discarded.  The final cell pellet was resuspended in 50 % glycerol and 
stored at -80°C. 
 
1.3 RESULTS AND DISCUSSION 
Cell culture conditions control expression levels 
 The original protocol for cell culture was as follows: inoculate 200 mL YES with 
individual hLTC4S  S. pombe colony.  The 200 mL YES was placed into an incubator 
shaker spinning at 250 rpm and 28°C for a non-specific amount of time, usually 1 – 2 
days.  After incubation in YES media, the S. pombe cells were spun down at 5000 x g for 
3 minutes until all growth media was spent and supernatant discarded.  The YES cell 
pellet was washed 2 – 3 times in ddH2O and finally resuspended and transferred to 3 L of 
fresh EMM media.  The 3 L of EMM media was placed into an incubator shaker spinning 
at 250 rpm and 28°C again, for a non-specific amount of time, anywhere from 2 – 7 days, 
obtaining on average a 30 g wet cell pellet after cell harvest was complete.  At one point, 
in a further attempt to harvest a larger cell culture population, the EMM was changed out 
multiple times to supply the cell population with fresh induction media.  The rationale 
behind longer and non-specific incubation times was to obtain a larger population of 
cells, of which would be expressing our target gene.  Upon closer inspection though, it 
was learned that tighter control of cell harvest conditions yielded higher quantities of 
target protein.  The original cell culture protocol was modified according to Schmidt-
Krey et al. (2004) and after cell harvest, an average weight of 7g wet cell pellet was 
obtained per liter of EMM media, after centrifugation at 7000 x g.  Expression of hLTC4S 
is controlled by the nmt1+ promoter.  In the presence of thiamine, the promoter is 
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repressed and gene expression does not occur.  Upon removal of thiamine in the growth 
media, the promoter is turned on and gene expression is also turned on.  Figure 1.6 shows 
sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) results after a 
side-by-side purification of two different cell culturing conditions.  The first cell culture 
was performed with 5 µM thiamine in both YES and EMM media, which should repress 
any gene expression.  The second cell culture was performed with 5 µM thiamine in the 
YES media only, which should repress gene expression in the YES and allow gene 
expression in the thiamine-free EMM.  All other conditions were held constant, including 
incubation temperature and time, culture volumes, and overall protein purification 
methods.  After purification using immobilized metal affinity chromatography (IMAC), 
hLTC4S was observed, at 18 kDa, only in the elution fractions where thiamine-free EMM 
media was used during cell culture.  This displays the inducible nature of hLTC4S 









Figure 1.6.  SDS-PAGE results comparing cell culture conditions.  Cell culture was 
varied in only one condition: the presence or absence of thiamine.  S. pombe contains an 
nmt1+ promoter.  In the presence of thiamine, gene expression is repressed.  In the 
absence of thiamine, gene expression is permitted.  A) Purification results, elution 1 – 3 
after IMAC, of cell culture harvest in the absence of thiamine in the EMM culture media.  
B) Purification results, elution 1 after IMAC, of cell culture harvest in the presence of 
thiamine in the EMM induction media.  hLTC4S is an 18 kDa MP.  Molecular weight, in 




As mentioned earlier, MP overexpression can become toxic to the cell, which can 
lead to accumulation within the lumen of the endoplasmic reticulum, triggering the 
unfolded protein response (UPR) (Griffith et al., 2003).  The UPR is a cellular stress 
response conserved in eukaryotes that aims to restore normal cell function by transiently 
decreasing protein translation and activating the endoplasmic reticulum-associated 
protein degradation (ERAD) system (Kaufman et al., 2002).  Successful over-expression 
in eukaryotes requires that translation of functional protein in the ER not exceed 
threshold levels that induce the UPR (Griffith et al., 2003).  Also mentioned earlier is the 
presence of endogenous proteases found in vacuoles of yeast that can affect protein 
integrity (Jones, 2002).  This could explain why longer cell culture times produced no 
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visible gene expression, because protein degradation occurred after maximal expression 
was achieved.  A possible alternative is the use of a previously published truncated 
derivative of the nmt1+ promoter (Kumar and Singh, 2006), which was found to repress 
expression in the presence of thiamine, but displayed temperature-dependent expression 
in the absence of thiamine: repression at 36°C and induction at 25°C, whereas full-length 
nmt1+ expresses at both temperatures.  Nmt1+ allows expression and maximum protein 
levels in 15 – 18 hours, whereas this truncated promoter construct can achieve maximal 
expression in only 3 hours.  This is advantageous because cells are exposed to possibly 
toxic levels of expressed protein for shorter induction times and because proteolysis 
levels may be reduced (Kumar and Singh, 2006). 
 
1.4 CONCLUSIONS 
 The over-expression of hLTC4S was successfully achieved using previously 
established methods.  Expression was induced by growth in thiamine-free media, which 
turns on the nmt1+ promoter and allows gene expression to occur.  MP over-expression 
can become toxic to the cell and may lead to issues such as degradation by endogenous 
proteases or accumulation in the endoplasmic reticulum by activation of the unfolded 
protein response (UPR).  Instead, tight control of cell harvest conditions via the nmt1+ 
promoter by monitoring OD600, removing thiamine from the induction EMM media, and 
culturing times between 16 – 20 hours proved to be the most useful determinants in the 
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2. PURIFICATION OF HUMAN LEUKOTRIENE C4 SYNTHASE 
 
2.1 BACKGROUND AND SIGNIFICANCE 
 
Membrane protein purification overview 
 
 The purification of MPs vary from that of soluble proteins in that MPs require the 
use of detergents to help remove the protein from the lipid bilayer in a process called 
solubilization.  Detergents are amphipathic molecules that mimic characteristic traits of 
lipid molecules within the membrane (Seddon et al., 2004).  Ideally, the detergent(s) used 
to solubilize the MP should efficiently remove the protein from its native host membrane, 
a heterogeneous and dynamic mosaic lipid bilayer, while maintaining the enzymes 
structure and functional activity (Abeyrathne et al., 2010).  Overall, MP purification can 
be organized into two major steps: isolating membranes and purifying the target protein, 
which is described in detail below. 
 
Isolating membranes 
 The lipid bilayer is a complex environment composed of several different types of 
lipid molecules; in order to reduce such complexities it is necessary to transfer the target 
protein to a more homogenous environment, such as a detergent micelle, and to remove 
other contaminant proteins.  In order for this to be done, the cell must first be disrupted to 
expose and free cellular components including membranes that contain the target protein.  
After cell lysis, the target protein is removed from the lipid membrane of the expression 
host by solubilizing the MP in detergent.  MPs are not soluble in aqueous solutions, and 
thus the goal is to obtain a water-soluble complex of protein-detergent molecules (Newby 
et al., 2009).  They are extracted form their native membrane by detergents, ampiphilic 
molecules with a polar head group and a hydrophobic chain, that satisfy the MPs need to 
 28 
be surrounded by a hydrophobic environment at transmembrane segments, and 
introducing cytosolic loops and domains to an aqueous phase (Seddon et al., 2004).  The 
detergent of choice is important because it determines MP solubility and stability and can 
affect the type and amount of co-purified lipids that remain after solubilization, 
purification, and crystallization (Aveldano, 1996 and Banerjee et al., 1995).  Co-purified 
lipids sometimes help to maintain protein stability and/or are essential to enzyme activity, 
and so excessive solubilization should not be pursued as it may deactivate the enzyme 
(Mosser, 2001). 
 There are four classes of detergents: ionic, non-ionic, bile acid salts, and 
zwitterionic (Figure 2.1).  Ionic detergents, such as sodium dodecyl sulfate (SDS), have a 
charged head group with a hydrocarbon or steroidal backbone.  Ionic detergents (Figure 
2.1a) are efficient solubilizers, but also denaturing.  Bile acid salts (Figure 2.1b) are ionic 
detergents that have rigid steroidal backbones resulting in a polar and apolar face, and no 
defined head group.  Bile acid salts are mild detergents and less denaturing than ionic 
detergents.  Non-ionic detergents (Figure 2.1c) have characteristic uncharged hydrophilic 
head groups.  These detergents are mild, relatively non-denaturing, and do not affect 
protein structure.  Non-ionic detergents break lipid-lipid and lipid-protein interactions 
and do not interfere with protein-protein interactions.  Finally, zwitterionic detergents 
(Figure 2.1d) have features similar to ionic and non-ionic detergents.  In general, they are 




Figure 2.1. Detergent classification.  The four classes of detergents, ionic, bile acid salts, 
nonionic, and zwitterionic detergents, are listed here, with respective molecular formulas 
(Seddon et al., 2004). 
 
 
 For the solubilization and purification of hLTC4S, two detergents are utilized: bile 
acid salt sodium deoxycholic acid (Na-DOC) and non-ionic detergent Triton X-100 (TX-










Table 2.1.  Properties of detergents used in the solubilization and purification of hLTC4S.  
The table summarizes properties of sodium deoxycholic acid (Na-DOC) and Triton X-




 The cellular membranes are solubilized by detergent(s) at a concentration about 
10X above the critical micelle concentration (CMC), for 12 – 14 hours at 4°C (Hays et 
al., 2010).  At concentrations equal to or above the CMC detergent monomers begin to 
self-associate and form micelles.  At concentrations well above the CMC, these detergent 
micelles can extract MPs from their native lipid membranes, producing a mixed micelle 
population of protein-detergent-lipid complexes, detergent-only micelles, and detergent 
monomers (Figure 2.2).  Unsolubilized material can then be removed by high-speed 
ultracentracentrifugation at > 100,000 x g, where they will be found in the pellet.  This 
helps to concentrate the MPs and remove soluble proteins that can degrade the target 
protein (Newby et al., 2009).  The MP of interest has now been removed from its native 
cellular membrane and is in a soluble form.  By definition, a solubilized protein is that of 
a MP surrounded by a detergent micelle and co-purified lipid molecules from the 





Figure 2.2.  Detergent solubilization of MPs.  At or above the critical micelle 
concentration (CMC), detergent monomers (blue) will begin to self-associate and form 
micelles (a, b).  Detergent micelles can then extract MPs from their native lipid bilayers 
(red) (c), forming a combination of protein-detergent-lipid complexes, detergent-only 




 One final consideration during MP solubilization is the critical micellar 
temperature (cmt), also known as the Kraft Point.  The cmt represents the temperature at 
which detergent monomers, detergent micelles and solid, crystalline detergent are in 
equilibrium.  Only above the cmt will detergent monomers dissolve to form micelles and 
be able to solubilize MPs (Seddon et al., 2004).  This is problematic because 
solubilization and purification steps for hLTC4S are conducted at 4°C, which may be 
lower than the cmt for Tx-100 and Na-DOC.  One study found that detergent micellar 
formation decreased with falling temperatures (Aveldano, 1995), most likely due to the 
inverse relationship between CMC and temperature: as temperature rises, CMC values 




 After detergent solubilization of the cellular membranes, it is necessary to isolate 
and purify hLTC4S from the remaining soluble proteins in order to obtain a pure, 
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homogenous and stable sample (Hays et al., 2010).  Throughout the purification it is 
necessary to keep the concentration of detergents in all buffers above their respective 
CMCs to prevent the protein from precipitating and crashing out of solution (Abeyrathne 
et al., 2010).  A variety of chromatographic techniques are available to assist in the 
purification of MPs, such as immobilized metal affinity (IMAC), size-exclusion (SEC), 
and ion-exchange chromatography (Hays et al., 2010).  IMAC and buffer exchange were 
employed to purify C-terminal His6-tagged hLTC4S.  IMAC is a type of affinity 
chromatography that utilizes histidine residues on the surface of proteins or recombinant 
proteins with engineered histidine tags.  It is composed of metal ligands (Ni2+, Co2+, Zn2+, 
Cu2+) covalently bound to a stationary phase, soft-gel nitrilotriacetic (NTA) matrix 
agarose (Porath, 1992).  These metal ions coordinate and bind specifically to histidine 
residues, where coordination occurs between an immobilized metal ion and electron 
donors from the protein surface (Porath, 1992).  After Ni-NTA binding, the agarose is 
washed with small concentrations (30 mM) imidazole, which helps to remove non-
specific, low-affinity bound proteins and reduce the presence of background contaminant 
proteins, without interfering with His6-tagged protein binding.  Finally, the Ni-NTA 
bound protein is eluted off the column with high concentrations of imidazole (100 – 250 
mM), which displaces the His6-tagged protein from the Ni-NTA agarose.  After IMAC, 
eluted fractions contain ~90% pure protein.  Other advantages of IMAC include ligand 
stability, high protein loading (5 – 50 mg His-tagged protein per 1 mL of Ni-NTA 
agarose resin), mild elution conditions, easy regeneration and low cost (Gaberc-Porekar 
and Menart, 2001).  Use of a His-tag also has its own advantages: modest size, smaller 
than most other purification tags; uncharged at physiological pH, and it has been shown 
to not interfere with protein structure and function (Gaberc-Porekar and Menart, 2001 & 




2.2 MATERIAL AND METHODS 
Materials 
 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) was purchased 
from Angus™ Chemicals, sodium chloride (NaCl) from BDH®, glycerol biotechnology 
grade from Amresco®, 2-mercaptoethanol from OmniPur®, imidazole from Acros®, 
ethylenediaminetetraacetic acid (EDTA) from Fischer Bioreagents®, L-glutathione 
reduced 97% (GSH) from Alfa Aesar®, and potassium chloride reagent ACS (KCl) from 
Acros®. 
 Detergents for solubilization, Triton X-100 and Na-DOC, were purchased from 
MP Biomedicals® and Fisher Scientific®, respectively. 
 Ni2+ charged resin for IMAC purification of histidine-tagged hLTC4S was 
purchased from 5Prime®. 
 Glycine was purchased from Sigma® Life Sciences, Coomassie® Brilliant Blue 
R-250 from Amresco®, bromophenol sodium salt from OmniPur®, protein marker 
(broad range 2 – 212 kDa from New England BioLabs® Inc., ammonium persulfate 
(APS) from MP Biomedicals®, N,N’-methylenebisacrylamine (bisacrylamide) from 
USB® Corporation, tris(hydroxymethyl)aminomethane (Tris) from Fisher Scientific®, 
and N, N, N, N’-tetramethylethylenediamine (TEMED) from GE Healthcare®, and 




 hLTC4S was purified according to Schmidt-Krey et al. (2004).  Cells over-
expressing hLTC4S were broken by mechanical lysis using the BioSpec® BeadBeater in 
ice cold Break Buffer (50 mM HEPES, pH 7.6; 10% glycerol, 0.5 M NaCl).  Successful 
cell lysis was confirmed visually using a light microscope.  After lysis, the cell-free lysate 
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was centrifuged at 7000 x g for 15 minutes at 4°C.  Unbroken cells, nuclei, and 
mitochondria remain in the pellet; soluble protein microsomes and other organelles 
remain in the supernatant.  The pellet was discarded and the supernatant retained.  The 
supernatant was then spun down at 200,000 x g for 2 hours at 4°C to collect the 
membranes.  Soluble proteins remain in the supernatant and the microsomes and other 
organelles are found in the pellet.  Above the dark brown hard pellet, a brown-beige layer 
of loose, liquid soft pellet is observed, where expressed protein is found.  Both hard and 
soft pellets were carefully collected for detergent solubilization. 
 
Detergent solubilization 
Membranes obtained from the previous step were solubilized in 1% (v/v) TX-100 
and 0.5% (w/v) Na-DOC on ice for 2 – 3 hours, with gentle nutation.  After detergent 
solubilization, any remaining unsolubilized material was removed by centrifugation at 
18,000 x g for 30 minutes at 4°C. 
 
Ni-NTA protein purification 
 Immobilized metal affinity chromatography (IMAC) was performed to purify the 
C-terminal His6-tagged hLTC4S from the detergent solubilized lysate.  Detergent-
solubilized hLTC4S was mixed with 2 mL of PerfectPro Ni-NTA agarose.  After 2 hours 
of Ni-NTA agarose binding, the lysate was transferred to a gravity column for column 
purification.  Incubation times greater than 3 hours are not recommended as it does not 
improve hLTC4S binding and may instead increase potential proteolysis and contaminant 
binding (Hays et al., 2010).  Next, very carefully, so as not to disturb the Ni-NTA 
agarose bed, the protein-bound agarose was washed with 50 CVs of wash I (50 mM 
HEPES, pH 7.6, 10% glycerol, 0.5 M NaCl, 45 mM imidazole, 1% TX-100, 0.5% Na-
DOC) and 25 CVs of wash II (50 mM HEPES, pH 7.6, 10% glycerol, 0.5 M NaCl, 70 
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mM imidazole, 1% TX-100, 0.5% Na-DOC).  The protein was eluted off the column with 
5 CVs of elution buffer (50 mM HEPES, pH 7.6, 10% glycerol, 0.5 M NaCl, 300 mM 
imidazole, 1% TX-100, 0.5% Na-DOC, 1 mM GSH, 1 mM EDTA, 10 mM 2-
mercaptoethanol, and 50 mM KCl).  When pouring the elution buffer into the gravity 
column, it is important not to disturb the Ni-NTA agarose bed and to reduce the flow rate 
during elution, as this will ensure that fractions collected from the column will be well-
resolved to the first 3 – 4 fractions and/or mLs. 
 
Buffer exchange 
 After IMAC purification of hLTC4S, the eluted protein fractions are then 
processed further by buffer exchange using the ÄKTAprime plus chromatography system 
and the 5 mL HiTrap Desalting Column.  The elution fractions collected from the IMAC 
column and the desalting buffer (50 mM HEPES, pH 7.6, 0.1 M NaCl, 10% glycerol, 1% 
TX-100, 0.5% Na-DOC, 1 mM GSH, 1 mM EDTA, 10 mM 2-mercaptoethanol, and 50 
mM KCl) were filter sterilized (0.1 µm pore size) to remove any aggregated material.  
After running a System Wash Method, the Manual Run method and the PrimeView 
software was used to monitor ultraviolet (UV) light and conductivity readings.  Once the 
UV reading began to rise, the sample was eluted off the column.  Protein elutions were 
collected between UV peaks, before conductivity began to rise.  This was performed for 
all IMAC protein fractions.  The detergent solubilized and purified protein was stored at -
80°C prior to two-dimensional crystallization trials. 
 
Protein detection: Western blot and SDS-PAGE 
 Detecting the presence of the purified protein hLTC4S was achieved by sodium 
dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE).  Samples collected 
through the course of the purification were treated with 5X SDS loading buffer (250 mM 
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Tris-HCl, pH 6.8; 10% SDS, 305 glycerol, 5% 2-mercaptoethanol, 0.02% bromophenol 
blue) and run on a 16% SDS-PAGE gel.  After electrophoresis the gels were stained with 
staining solution (0.3% Coomassie Brilliant Blue R-250, 50% methanol, 10% acetic acid, 
and 40% ddH2O) and destained with destain solution (50% methanol, 10 % acetic acid, 
and 40 % ddH2O).  Gels were stored in ddH2O at room temperature. 
 
Protein concentration quantification: BSA & densitometry 
 Protein concentration after purification was assessed by SDS-PAGE using bovine 
serum albumin (BSA) to create a standard curve on SDS-PAGE gels and comparing it to 
unknown quantities of our protein of interest, hLTC4S, by densitometry.  Densitometry 
quantifies protein loads by comparatively measuring the intensity of Coomassie Blue 
stain (Vincent et al., 1997).  Using SDS-PAGE with BSA standards will reveal the total 
amount of protein recovered after expression and purification.  It does not give any 
information as to what proportion is biologically active, so activity assays like ligand 
binding assays should be performed to determine the activity of the purified protein 
(Grishammer and Tate, 1995). 
 
2.3 RESULTS AND DISCUSSION 
Western blot of hLTC4S 
 To confirm the purification and presence of hLTC4S, a Western blow was 


















Figure 2.3.  Western blot for hLTC4S detection.  Western blot analysis identified the 




Purification of hLTC4S 
 
 The purification of hLTC4S was successfully reproduced following previously 
published methods from Schmidt-Krey et al. (2004), with slight modifications.  Instead 
of purifying the protein using S-hexyl glutathione agarose for affinity chromatography, 
IMAC was employed to purify the C-terminal His6-tagged target protein, following a 
final desalting step to help remove contamination proteins.  This modified protocol is 
optimized because it allows for the purification of suitable amounts of protein, ~0.8 mg 
per liter of cell culture.  From start to finish, the modified protocol can be performed in 
less than one day, and so exposes the MP to potentially denaturing detergents for short 
amounts of time, which could subsequently lead to the recovery of more stable purified 
protein.  Also, after IMAC several high and low molecular weight contaminants are 
observed, including a 34, 27, 16, 14, and 6.5 kDa band.  These contaminant bands are 
almost completely removed after buffer exchange, yielding > 90% purity for subsequent 
2D crystallization trials (Figure 2.4).  Buffer exchange was performed to change the 
purified proteins sitting buffer conditions, from the elution buffer to the desalting buffer 
hLTC4S 
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Figure 2.4.  SDS-PAGE gels after after hLTC4S WT purification: before and after buffer 
exchange.  Detergent solubilized hLTC4S was purified using two steps of column 
chromatography.  A) First, IMAC was utilized to purify the C-terminal His6-tagged 
hLTC4S.  B) Next, buffer exchange was performed to remove imidazole and NaCl from 
the buffer of the purified protein.  After buffer exchange, several contaminants were 




 Protein samples were not boiled prior to SDS-PAGE analysis because MPs will 
aggregate irreversibly when heated, visibly precipitating inside the bottom of the gel well 
and not migrating towards the anode of the SDS-PAGE and so cannot be visibly detected 




 The purification of both WT and mutant R104A hLTC4S was successfully 
reproduced using a modified version of a previously established protocol by Schmidt-
Krey et al. (2004).  The established protocol was modified to remove the S-hexyl 
glutathione agarose for affinity chromatography due to low purification yields, which 
most likely is a result of manufacturer inconsistencies.  Instead IMAC and buffer 
exchange were employed to purify hLTC4S.  The modified purification protocol can be 
completed in less than one day, reducing the amount of time that target protein is exposed 
to potentially denaturing detergents.  The target protein was purified to apparent 
homogeneity according to SDS-PAGE.  ~0.8 mg of protein was purified per liter of 
















Figure B.1.  Precision Plus Protein™ Kaleidoscope Standards. 
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3.  TWO-DIMENSIONAL CRYSTALLIZATION OF HUMAN 
LEUKOTRIENE C4 SYNTHASE 
 
3.1 BACKGROUND AND SIGNIFICANCE 
 
Overview of previous work done for hLTC4S 
 Structure-function studies of hLTC4S rely on previous work established on the 
enzyme.  A brief description of the history of hLTC4S will be described.  hLTC4S was 
first purified in 1992 from the KG-1 myeloid cell line.  Microsomes were solubilized in 
0.4% Na-DOC and 0.4% Triton X-102 following purification using an S-hexyl-
glutathione agarose column (Penrose et al., 1992).  Expression cloning of the cDNA for 
hLTC4S, from the KG-1 cDNA expression library, was performed by Lam et al. (1994), 
revealing that hLTC4S belongs to the MAPEG family of proteins, which was first defined 
in 1999 (Jakobsson et al.,1999).  The nucleotides of the hLTC4S gene were isolated and 
sequenced by Penrose et al. (1996) demonstrating that hLTC4S and FLAP are highly 
conserved.  Functional characterization of hLTC4S was assessed by site-directed 
mutagenesis, focusing on shared and conserved amino acid residues between hLTC4S and 
FLAP.  Specifically, these residues include Arg51, Tyr59, Tyr97, Tyr93, Asn55, Val49, 
Ala52, and Arg104.  A putative mechanism for hLTC4S proposed Tyr93 activated the 
thiolate anion of GSH and Arg51 opened the epoxide of LTA4 (Lam et al., 1997).   
Oligomerization of functionally active hLTC4S has been the topic of debate for 
several years because various papers presented conflicting data: gel filtration 
chromatography suggested the presence of a homodimer (Nicholson et al., 1993), 
bioluminescence energy transfer proposed that hLTC4S forms a homooligomer (Svartz et 
al., 2003), and fluorescence energy transfer and crosslinking studies indicate that hLTC4S 
forms a hetero-dimer or hetero-trimer with FLAP (Mandal et al., 2004).  The 
oligomerization of hLTC4S was first confirmed by Schmidt-Krey et al. in 2004.  A 
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projection map, produced by electron crystallography of well-ordered 2D crystals at 4.5 
Å resolution showed that hLTC4S crystallizes as a homotrimer with p321 symmetry 
(Figure 3.1).   A projection map displays a three-dimensional body on a plane of two 
dimensions, which provides a top-down view of the protein.  Projection densities 
revealed the presence of four transmembrane helices that run near perpendicular to the 
membrane.  hLTC4S crystals form a lattice with plane group symmetry p321 with unite 
cell dimensions of a = b = 73.4 Å, γ = 120°.  One hLTC4S monomer is about 20 by 22 Å 
in dimension, while a trimer is about 43 Å in diameter.  This study confirmed for the first 




Figure 3.1.  Projection map of hLTC4S.  Projection map of hLTC4S was solved by 
electron crystallography of 2D crystals.  The projection map shows two trimers, circled 
by dashed and dotted lines, showing opposing membrane insertion orientations.  Each 
trimer displays 12 circular densities, four per monomer.  Two-fold axis indicated by 
arrows (Schmidt-Krey et al., 2004). 
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The 3D structure of hLTC4S was first solved in 2007 by two different groups 
(Ago et al., 2007 and Molina et al., 2007), both by x-ray crystallography.  Ago et al. co-
crystallized the enzyme with GSH to produce a 3D structure at 3.3 Å resolution.  Molina 
et al. crystallized both the apo-enzyme and GSH-bound enzyme at 2.00 and 2.15 Å 
resolution, respectively.  Both authors reported similar findings, which closely agreed 
with Schmidt-Krey et al. (2004).  hLTC4S crystallizes as a homotrimer with threefold 
symmetry, where each monomer is composed of five α-helices.  Helices I – IV are 
transmembranous and helix V is found in the perinuclear space (Figure 3.2).  The GSH 
binding site revealed several amino acid residues that interact with the substrate, 









Figure 3.2.  X-ray crystal structure of hLTC4S solved by x-ray crystallography to 3.3 Å 
resolution.  The structure revealed a homotrimer, with each monomer composed of five 
α- helices, four of which are located within the membrane, and the final fifth helix 
protrudes into the perinuclear space.  The three colored segments (grey, pink, and brown) 
represent monomers and one GSH molecule is shown in space-filling model, while the 


















 Electron crystallography of hLTC4S 
 
 Electron crystallography is a developing field in structural biology, 
complementary and alternative to methods such as x-ray crystallography and nuclear 
magnetic resonance (NMR) spectroscopy, in the structural and functional studies of MPs.  
Electron crystallography relies on the growth and analysis of large, well-ordered two-
dimensional crystals by electron microscopy (Kühlbrandt, 1992, Schmidt-Krey, 2007, 
and Abeyrathne et al., 2010).  The methods that first helped to develop the field of 
electron crystallography came from Richard Henderson and Nigel Unwin in 1975 with 
the structural determination of purple membrane, a MP that naturally forms 2D arrays 
(Henderson and Unwin, 1975), and which was further refined to atomic resolution in 
1996 (Grigoriegg et al., 1996).  The first atomic-resolution structure was solved by x-ray 
crystallographic techniques by Johann Deisenhofer and Hartmut Michel of the 
Rhodopseudomonas viridis photosynthetic reaction center in 1985 (Deisenhofer et al., 
1985). A total of 308 unique structures of MPs have been solved to date (Figure 3.3) 
(White, 2009), most of which have been solved by x-ray crystallography.  This is in stark 






Figure 3.3.  Progress in MP structure determination.  The number of unique MP 
structures solved, since the first atomic-resolution structure of photosynthetic center in 
1985, has grown tremendously.  As of 2011, 208 unique MP structures have been solved, 
but this is in stark contrast to 80,000 + structures deposited in the PDB, which are mostly 
of soluble proteins (Http://blanco.biomol.uci.edu/mpstruc/listAll/list).  
 
 
Structure determination by electron crystallography is advantageous because 
electron crystallography of 2D crystals is well-suited to study proteins in varying 
conditions (Kühlbrandt, 2012), such as pH-induced changes observed in sodium-proton 
antiporters NhaP and NhaA (Vinothkumar et al., 2005 and Appel et al., 2009).  Also, 2D 
crystals are composed of ordered MPs embedded within a continuous lipid bilayer, 
closely resembling what would be seen in vivo.  Another benefit to 2D crystallization is 
that the MP is exposed to high concentrations of detergent only during the experimental 
portions of solubilization and purification, whereas in x-ray crystallography the target 
protein is exposed to detergents during the solubilization, purification and crystallization 
experiments, which may lead to protein instability (Abeyrathne et al., 2010).  The major 
limiting factor for successful MP crystallization is the growth of large, well-ordered and 
thus diffraction quality crystals (Seddon et al., 2004).  For microsomal glutathione 
transferase 1 (MGST1) is was shown that slower crystallization rates resulted in the 
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growth of larger crystals that were related to the length of dialysis time (Schmidt-Krey et 
al., 1998).  To date, only a handful of MP structures have been solved to greater than 4 Å 
resolution, including bacteriorhodopsin at 3.5 Å resolution (Kühlbrandt, 1994), 
aquaporin-1 at 3.7 Å resolution (Ren et al., 2000), MGST1 at 3.2 Å resolution (Holm et 
al., 2006) and aquaporin-0 at 1.9 Å resolution (Gonen et al., 2005), which is the highest 
resolution 3D structure of a MP obtained by electron crystallography of 2D crystals to 
date. 
There are several differences between electron crystallography and x-ray 
crystallography.  Electron crystallography requires less protein as lower concentrations of 
purified protein, only 0.5 – 1 mg per mL (Ubarretxena-Belandia and Stokes, 2010), are 
required for systematic investigations of optimal crystallization parameters.  It should be 
noted that 2D crystallization trials require a larger volume of purified protein than 3D 
crystallization requires, but still need less concentrated protein for 2D crystallizations.  
Screening of crystallization conditions requires that specimen be inspected individually 
by electron microscopy.  In terms of size, 2D crystals are smaller and measure 0.5 – 5 µm 
or larger in diameter, whereas 3D crystals require a minimum size of 100 µm for x-ray 
diffraction.  In terms of crystallization conditions, 2D crystal formation occurs at low to 
moderate ionic strength and neutral pH, whereas 3D crystal formation occurs at high 
ionic strength and slightly acidic and/or basic pH values (Abeyrathne et al., 2010, Newby 
et al., 2009).  Electron crystallography and x-ray crystallography have one main step in 
common: the iterative pathway for structure determination, especially when in the 
crystallization phase of the experimental workflow.  Once crystals have been grown, it 
can take anywhere from weeks to months to obtain well-ordered and large crystals, where 
within this time range parameters critical to crystal formation are adjusted in a step-wise 
and systematic manner to refine and optimize the conditions to maximize crystal size and 
quality (Newby et al., 2009). X-ray and electron crystallography can be combined to 
study MPs (Kühlbrandt, 2012).  For example, if the x-ray structure of a homologous 
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protein is available, atomic models can be built as was done for NhaP1 (Goswami et al., 
2011). 
Electron crystallography of hLTC4S may reveal important structural information, 
as the protein is crystallized in lipid instead of detergent.  There are still unanswered 
questions about the mechanism of product formation.  How does hLTC4S conjugate two 
very different substrates, hydrophilic GSH and hydrophobic LTA4?  How does LTA4 
approach the enzyme active site, from above or within the membrane?  There are difficult 
questions to tackle experimentally because LTA4 is very unstable in solution. 
 
Reconstitution of protein into a lipid bilayer 
After detergent solubilization and purification of the target protein, which is 
obtained well beyond the CMC, excess detergent must be removed, in the presence of 
exogenous lipid, in order to reconstitute the MP into an artificial bilayer in solution 
(Abeyrathne et al., 2010).  This can be obtained through a variety of techniques: dialysis, 
hydrophobic absorption, dilution, and the use of cyclodextrins (Kühlbrandt, 1992, 
Remigy et al., 2003, Signorell et al., 2007).  Dialysis was used for hLTC4S 
reconstitution, therefore the later three methods will be described briefly.  Hydrophobic 
absorption relies on the use of insoluble, hydrophobic “beads” that attract the 
hydrophobic tails of detergent molecules.  After absorption, beads can be removed by 
centrifugation.  Hydrophobic absorption is most successful at removing detergents with a 
low CMC (Seddon et al., 2004).  The dilution method dilutes mixed protein, lipid and 
detergent solutions at known dilution factors.  Dilution yields fairly reproducible results 
and is a method most recommended for high CMC detergents (Mosser, 2001).  Finally, 
cyclodextrins are ring-shaped molecules with a non-polar ring environment that interact 
with detergents regardless of classification or CMC.  Cyclodextrins do not interact with 
lipids because they have a higher affinity for detergent, and so do not affect reconstitution 
parameters (Abeyrathne et al., 2010). 
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Reconstitution of hLTC4S into a lipid membrane was achieved via dialysis, 
according to Schmidt-Krey et al. and Zhao et al. (Schmidt-Krey et al., 2004 and Zhao et 
al., 2010).  Dialysis is one of the most popular methods used to remove detergent from 
the detergent-solubilized purified protein solution.  In this method, a ternary mixture of 
detergent, target protein, and lipid are combined and dialyzed against detergent-free 
buffer, within dialysis membranes with molecular weight cutoff (MWCO) large enough 
to allow the movement of detergent monomers out of the membrane but small enough to 
retain the target protein.  The hydrophobic fatty acid chains of the lipid molecules 
strongly prefer to be in contact with the hydrophobic parts of the MP, while detergent 
monomers dissociate from the micelle-surrounded target protein at concentrations below 
their CMC.  Lipid molecules begin to insert into the micelle, forming proteoliposomes.  
Lipid should be equilibrated with the detergent-protein mixture before detergent removal 
is attempted, because although detergent exchange between micelles is rapid, lipid 
molecules cannot move freely in aqueous solution (Kühlbrandt, 1992).  Over a period of 
several days reconstitution of the target protein into a synthetic lipid bilayer will occur, 
forming 2D crystals (Seddon et al., 2004 and Abeyrathne et al., 2010). 
 The dialysis method is more practical for detergents with a high CMC as the rate 
of dialysis is determined by the CMC of the detergent, with low CMC detergents 
dialyzing more slowly than high CMC detergents.  This is potentially advantageous for 
detergents with low CMCs as the slow detergent removal rates may aid in the growth of 
well-ordered, large 2D crystals (Schmidt-Krey et al., 1998).  There are several examples 
of 2D crystal growth of MPs solubilized by low and high CMC detergents, followed by 
detergent removal via dialysis.  These include MGST1 (Schmidt-Krey et al, 2000), NhaA 
(Williams, 2000), EmrE (Ubarretxenna-Belandia et al., 2003), AQP-0 (Gonen et al., 
2005) and NhaP1 (Goswami et al., 2011).  Na-DOC is a high CMC detergent (0.08 – 
0.25% w/v), but TX-100 is a low CMC detergent (0.015%).  Dialysis exposes the 
detergent to an excess of detergent-free buffer, helping to bring it below its CMC so that 
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detergent micelles will dissociate into individual monomers, which can easily be removed 
by dialysis (Seddon et al., 2004). 
 2D crystals are composed of protein, lipid and sometimes detergent.  2D crystal 
formation is dictated by the interactions between these individual components.  Upon 
detergent removal of the ternary detergent-protein-lipid mixture, the target protein can 
either insert into pre-formed lipid membranes or aggregate together.  The formation of 
these 2D crystals is believed to occur in one of three different models: the one-, two-, or 
three-stage process (Kühlbrandt, 1992).  In the three-stage model, lipid bilayer sheets of 
vesicles form as detergent is removed.  Next, protein molecules insert into these 
membranes in random orientation and finally, the protein arranges itself in an ordered 
orientation onto a 2D lattice.  The two-stage model describes the first two steps occurring 
simultaneously, and the one-stage model describes all three steps occurring 
simultaneously (Kühlbrandt, 1992). 
 Upon MP reconstitution for electron crystallography, two different crystal types 
can form: 2D crystals or stacked 2D crystals (Figure 3.4).  2D crystals are thin, and 
depending on the target protein, range from 50 – 200 Å in thickness.  The formation of 
2D crystals is dictated primarily by hydrophobic interactions, primarily between MP 
contact points.  2D crystals can present in different membrane morphologies such as 
planar sheets, vesicles or tubes.  Rarely, crystalline patches can form in native 
membranes (Figure 3.4a) (Stoeckenius et al., 1979).  These 2D crystals contain protein 
facing one direction because the protein does not dissociate from the membrane for 
crystallization, and instead undergoes rearrangement.  Vesicles are collapsed membranes 
that sometimes contain protein facing one direction (Figure 3.4b) or in alternating 
directions (not shown).  Vesicles are energetically stable, as they do not have any open 
edges where hydrophobic portions of lipid or protein are exposed to the aqueous solution 
(Abeyrathne et al., 2010).  Tubular crystals are elongated vesicles with protein arranged 
helically along the outer surface of the vesicle.  Planar-tubular crystals are similar to 
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tubular crystals, but are wider in diameter.  Planar-tubular crystals are more common 
after two-dimensional crystallizations and contain two crystal lattices.  Figure 3.4c 
displays a cross-section of the tubular crystal.  Sheets contain protein molecules 
embedded in alternating directions where energetically unstable edges of hydrophobic 
portions of lipid and protein are exposed t o aqueous solution (Figure 3.4d).  Sometimes 
2D crystals of sheets will stack upon each other, forming multilamellar crystals or thin 
3D crystals.  This is due in part to polar interactions like ionic strength and pH 
(Abeyrathne et al., 2010).  Figure 3.4e represents these thin 3D crystals, with protein 
molecules stacked exactly in register.  Finally, it should be noted that 2D crystals limit 
protein freedom of movement in two dimensions, which should help improve the 









Figure 3.4.  Membrane protein crystal types.  After reconstitution, MPs can form three 
different types of crystals: 2D (a-d), 3D (f), and stacked 2D crystals (e).  a) 2D crystals of 
native membrane and b) vesicles have protein insertion occur in the same direction.  c) 
Elongated vesicles can form planar-tubular or tubular crystals.  d) Typically seen after 
reconstitution experiments are 2D crystals with alternating protein insertion.  These 2D 
crystals can stack to form thin 3D crystals (e).  Finally, 3D crystals are grown for x-ray 





 Initial crystallization trials should systematically test a range of LPRs between 0 
and 1 (w/w) (Mosser, 2001) or between 1 and 30 (mol/mol) (Schmidt-Krey et al. 2007).  
Ideally, protein reconstitution will occur over a range of LPR values (Gulik-Krzywiki, 
1987).  Upon the initial growth of 2D crystals, lowering the LPR can help improve 
crystallization (Schmidt-Krey et al., 1998, Mosser, 2001, Schmidt-Krey et al., 2004, 
Schmidt-Krey et al., 2007).  The ideal LPR for successful 2D crystal growth is small 
enough to promote crystal contacts and high enough to prevent protein aggregation 
(Schmidt-Krey et al., 2007, Abeyrathne et al., 2010).  A starting population of pure 
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protein is ideal because as protein crystallization occurs, the presence of any existing 
contaminants may interfere with lattice formation (Kühlbrandt, 1992). 
 The lipid of choice for MP reconstitution is important for 2D crystallization 
(Ubarretxena-Belandia and Stokes, 2010).  The length of the fatty acid tail influences 
overall fluidity and thickness of the bilayer.. Biological membranes consist of a wide 
range of phospholipid molecules including diacylglycerol lipids with fatty acid tails 16 or 
18 carbon atoms long.  Bilayers form when the cross section of the polar head group and 
hydrophobic fatty acid tails are roughly the same size.  If the head group is larger, micelle 
formation is common; if the head group is smaller, inverted micelles can form 
(Kühlbrandt, 1992).  1,2-dimyristory-sn-glycero-3-phosphocholine (DMPC) was selected 
for the reconstitution of hLTC4S.  DMPC is a lipid with less than the ideal 16 or 18 
carbon atom fatty acid tail length.  Instead, DMPC is a saturated synthetic lipid with 14 
carbon atom chain length, a zwitterionic phoscholine (PC) head group, and a phase 
transition temperature of 23°C.  The phase transition temperature refers to the 
temperature at which a rigid, lamellar bilayer transitions to a rigid, crystalline phase.  
Crystallization usually, but not always (Schmidt-Krey et al., 2007), occurs at 
temperatures above the phase transition temperature (Kühlbrandt, 1992).  Although 
DMPC has a shorter fatty acid chain length, it forms bilayers of 35 Å hydrophobic 
thickness, similar to the 35 Å hydrophobic center of a biological lipid bilayer.  DMPC 
has been employed in the 2D crystallization of several MPs including photosystem I 
(Karrasch et al., 1996), photosystem II (Tsiotis et al., 1996), MGST1 (Schmidt-Krey et 
al., 2000), porin OmpF (Signorell et al., 2006), and human vitamin K-dependent γ-
glutamyl carboxylase (Schmidt-Krey et al., 2007). 
After MP reconstitution into a lipid bilayer, potential 2D crystals must be 
screened using an electron microscope, as 2D crystals are too small to view by light 
microscopy.  In general, screening and detection of 2D crystallization trials is performed 
by negative stain of post-dialysis samples (Kühlbrandt et al., 1994).  Due to the natural 
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low contrast observed in biological specimen, negative stain is used to provide high 
contrast of the specimen.  Negative stains are heavy metal compounds.  Non-uniform 
sample staining can result in the appearance of high contrast specimen in one area, and 
featureless regions in another area, which should be taken into account during screening 
of 2D crystals (Kühlbrandt, 1992). 
 
3.2 MATERIALS AND METHODS 
Materials 
 DMPC was purchased from Avanti® Polar Lipids, Inc. in 1 mg and 10 mg 
concentrations (lot # 140PC-254).  The Spectra/Por® Dialysis Membrane 2 with a 
molecular weight cutoff (MWCO) of 12,000 – 14,000 Da and the Spectra/Por® closures 
were both purchased from Spectrum® Labs.  Reagents for dialysis include HEPES 
purchased from Angus® Chemical Company, glycerol biotechnology grade from 
Amresco®, 2-mercaptoethanol (2-ME) from OmniPur®, ethylenediaminetetraacetic acid 
(EDTA) from Fisher Bioreagents®, L-glutathione reduced 97% (GSH) from Alfa 
Aesar®, and potassium chloride (KCl) from Acros®.  Materials for electron microscopy 
include 400 mesh TEM regular grids (Cu, 3mm), purchased from SPI® Supplies, uranyl 





 In order to confirm that the protein is enzymatically functional, activity assays of 
the detergent solubilized protein and the post-dialysis samples were performed according 
to Lam et al. (1997).  Activity assays were performed by our collaborating lab (Bing K. 
Lam, Department of Medicine Brigham and Women’s Hospital, Boston).  hLTC4S 
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activity is measured by reverse phase high-performance liquid chromatography (RP-
HPLC) assessing LTC4-ME formation.  Purified protein is incubated at room temperature 
along with GSH and LTA4-Me.  The enzymatic reaction is stopped by the addition of 
methanol and water.  Prostaglandin B2 (PGB2) is added as an internal standard prior to 
RP-HPLC.  LTC4 is quantitated by the ratio of the LTC4 peak compared to the PGB2 
internal standard. 
 
Protein reconstitution: dialysis setup 
 The lipid was solubilized in Na-DOC, according to Schmidt-Krey et al. (Schmidt 
Krey et al., 1998 & 2000): 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC), stored 
in chloroform, is carefully transferred to a round bottom flask.  The chloroform is 
evaporated under a gentle stream of nitrogen gas.  After chloroform evaporation, 0.5% 
Na-DOC is added to solubilize the dried lipid, sonicated for 5 minutes and stored at -
20°C. 
 The 2D crystallization of hLTC4S was performed according to Schmidt-Krey et 
al. and Zhao et al. (Schmidt-Krey et al., 2004 and Zhao et al., 2010).  Exogenous lipid 
DMPC is added to the purified protein (see LPR Calculation).  Rest on ice for 30 minutes 
and then pipette the ternary mixture of detergent-protein-lipid to an 8-cm long section of 
1 cm flat width dialysis tubing (MWCO 12,000 – 14,000 Da).  Dialyze against 250 mL of 
detergent-free dialysis buffer (50 mM HEPES, pH 7.6; 20% glycerol, 1 mM EDTA, 10 
mM 2-mercaptoethanol, 10 mM GSH and 50 mM KCl) for 3 – 8 days at 23°C. 
 
LPR determination 
 The lipid-to-protein ratio (LPR) defines the amount of lipid added to a solubilized 
protein solution for reconstitution to occur.  The LPR was the main experimental variable 
that was adjusted during 2D crystallization trials of hLTC4S, with a focus on 
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reconstitution at lower LPR ranges.  The LPR values stated below are all molar values, 
unless otherwise stated.  The calculation for LPR (mol/mol) is as follows: 
 
LPR = nlipid/nprotein = [(Clipid * Vlipid) / MWlipid] ÷ [(Cprotein * Vprotein) / MWprotein] (eqn 1) 
 
Eqn 1 describes the calculation for LPR (mol/mol) determination, where n = number of 
molecules, C = concentration (mg/mL), V = volume (mL) and MW = molecular weight 
(Da).  A sample LPR (mol/mol) calculation can be seen below for a dialysis setup using 
100 µL of hLTC4S, purified to 0.8 mg/mL, using 1 mg/mL DMPC, and solving to a final 
LPR of 10: 
 
10 = [(1 mg/mL * Vlipid) / 678.15 Da] ÷ [(0.8 mg/mL * 100 µL) / 50,000 Da]  
Vlipid = 10.8 µL 
 
The calculation for LPR (w/w) is as follows: 
 
LPR = wlipid/wprotein = (Clipid * Vlipid) ÷ (Cprotein * Vlipid)  (eqn 2) 
 
Eqn 2 describes the calculation for LPR (w/w) determination, where w = weight (mg), C 
= concentration (mg/mL) and V = volume (mL). 
 
Grid preparation of 2D crystals 
 After 3 – 10 days the sample is removed from dialysis for grid preparation.  Any 
remaining post-dialysis sample is flash-frozen in LN2 and stored at -80°C.  2D 
crystallization conditions of hLTC4S are screened by electron microscopy.  2D crystals 
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are stained with 1% uranyl acetate on a carbon coated copper 400 mesh grid.  The grid is 
stored in a grid storage box and placed inside a desicator cabinet. 
 
Screening 2D crystals by electron microscopy 
 Post-dialysis samples were negatively stained with uranyl acetate.  2D crystals 
were screened using a JEM-1400( JEOL® Ltd.) transmission electron microscope (TEM) 
with 120 kV accelerating voltage, equipped with Gatan Orius SC1000 and Ultrascan 
1000 charge-coupled device (CCD) cameras.  Images of membranes and 2D crystals 
were obtained at magnifications ranging from 25K (Gatan Orius SC1000) to 50K 
(Ultrascan 1000 CCD camera). 
 
3.3 RESULTS AND DISCUSSION 
 Activity assays for hLTC4S 
 The activity of hLTC4S was measured after two experimental steps: after 
purification (before dialysis) and after dialysis (Table 3.1).  hLTC4S showed no activity 
after purification.  This represents the detergent solubilized and purified protein.  This 
result is not surprising as hLTC4S solubilization and purification requires the utilization 
of excess detergent, which is possibly denaturing.  hLTC4S was solubilized in 1% TX-
100 (CMC = 0.015% v/v) and 0.5% Na-DOC (CMC = 0.08 – 0.25% w/v), about 67X and 
3X in excess to their CMC, respectively.  The lack of enzymatic activity prior to 2D 
crystallization trials is not ideal, but what is more surprising and ultimately more 
important, is that hLTC4S activity after dialysis was high.  This displays the critical 
importance of reconstitution with added exogenous lipid for enzyme activity.  Also, 
greater activity was seen with the high LPR value in the post-dialysis samples, possibly 
suggesting that increased activity may be the result of reconstituted 2D crystals.  This 
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LPR range, between 10 and 15, was shown to produce sheets and stacked 2D crystals, 
respectively.  This is discussed in further detail below. 
 
Table 3.1.  Activity assays of hLTC4S.  Enzymatic activity, assessed by the production of 
LTC4-Me, was measured for 2 sets of samples: pre-dialysis and post-dialysis.  The pre-
dialysis samples, which simply represent a population of detergent solubilized and 
purified proteins, showed no activity.  However, the post-dialysis samples, which 
represent a population of purified protein after detergent removal and reconstitution into a 
lipid bilayer, showed high activity.  This is due in part to the denaturing effects of high 





2D crystals of hLTC4S  WT 
 The main parameter that was varied during 2D crystallization trials of hLTC4S 
was the lipid-to-protein ratio (LPR).  It has been reported that careful selection of eluted 
protein fractions (instead of using batch and/or pooled purification elutions) and the LPR 
were critical factors that determined the success of 2D crystallization trials (Zhao et al., 
2010).  Following these guidelines, the LPR was again systematically tested for the 
growth of 2D crystals.  Additionally, time in dialysis was found to yield interesting 
results, such as the growth of 2D crystals after only 3 days in dialysis, and so was added 
to the list of varied parameters in this study.  Overwhelmingly, the most common 
membrane morphology that was obtained after dialysis of hLTC4S was the growth and 
formation of stacked 2D sheets (Figure 3.5), varying from 0.1 – 10 µm in size.  Within 
these stacked sheets a visible 2D lattice(s) was observed, that varied with LPR and time 



























Figure 3.5.  Stacked 2D crystal formation of hLTC4S WT after 8 days in dialysis.  Thin 
stacks of 2D sheets formed after 8 days in dialysis.  a)  Low-mag micrograph of 




Figure 3.5.  Stacked 2D crystals formation of hLTC4S WT after 8 days in dialysis..  a) 
Low-magnification micrograph of negatively stained hLTC4S.  Sheets 0.1 – 1 µm in 
width are observed.  Areas with single and multiple layers of membranes are apparent.  b) 
High-magnification micrograph of boxed area in a).  2D crystalline lattice is visible, ~100 
nm in width.  Fast Fourier transform (FFT) of boxed area (red) inset displays six sharp 
spots.  The spots of an FFT encode for the amplitude and phase of the protein structure 







Table 3.2  2D crystallization parameters of hLTC4S WT.  Variation of two conditions 
(LPR and time in dialysis) yielded substantially different results.  The table below shows 














56 E1 0.10 0 0 8 Aggregated protein 
56 E1 0.10 5 0.067 8 Aggregated protein 
56 E1 0.10 10 0.135 8 Sheets; no order 
56 E1 0.10 15 0.202 8 Stacked sheets; crystals 
56 E2 0.23 0 0 8 Aggregated protein 
56 E2 0.23 5 0.067 8 Aggregated protein 
56 E2 0.23 10 0.135 8 Aggregated protein 
56 E2 0.23 15 0.202 8 Stacked sheets; crystals 
 
  
Overall, 2D crystallization trials of hLTC4S followed the general rules of LPR-
dependent 2D crystal growth (Figure 3.6) (Schmidt-Krey et al., 2004, Zhao et al., 2010).  
At low LPR ranges, between 0 – 5, protein aggregation was observed (Figure 3.6a).  At 
high LPR ranges, between 6 – 15 (Figure 3.6a and 3.6b), a variation between sheets and 


















Figure 3.6.  LPR-dependent 2D crystallization of hLTC4S.  a) At low LPRs, from 0 – 5, 
protein aggregation was observed, b) at LPR 10 sheets were seen, and c) at high LPRs of 
15, stacked sheets were observed. 
 
 
 Stacked 2D crystals sometimes exist as a combination of in-plane hydrophobic 
interactions and hydrophilic interactions between lateral sheets.  One explanation for the 
occurrence of stacked sheets is the presence of hydrophilic interaction between cytosolic 
loop portions connecting transmembrane segments.  This is common especially when the 
target protein has large extramembranous domains.  Crystal stacking is undesired because 
electrons interact with matter 10,000X more strongly than x-rays, emphasizing the need 
for extremely thin specimen.  Although the stacks of 2D crystals are relatively thin, they 





Figure 3.6.  LPR-dependent 2D crystallization of hLTC4S.  a) At low LPR, from 0 – 5, 
protein aggregation was observed, b) at LPR 10 sheets were observed, and c) at high LP 




 Stacked 2D crystals exist as a combination of in-plane hydrophobic interactions 
and hydrophilic interactions between lateral sheets.  Stacked crystals tend to be small in 
size due to experimental conditions that strengthen either of these i teractions.  2D 
crystal formation is predicted to occur in thr  stag s.  First, mall crystalli e patches, 0.5 
– 1 µm wide, form after 12 hou s at 25°C.  Next, these small patches fuse together, 
forming mosaic arrays, fter 36 hours at 25°C.  Finally, the te peratur  s ramped up to 
35 - 40°C for 2 hours and the mosaic rrays merge into one larg  single l ttice 
(Kuhlbrandt, 1992).  One explanation f r the occurrence of stacked sheets is the pres nce 
of hydrophilic interaction between cytosolic loop portions connecting transmembrane 








tilted specimen.  Tilting specimens of thin 2D stacks does not provide useful information 
for three-dimensional structure analysis (Kühlbrandt, 1992). 
 There are several examples of stacking of 2D sheets upon reconstitution.  
Cytochrome reductase, solubilized in TX-100, was crystallized using two different 
detergent removal methods: adsorption using polystyrene beads (Wingfield et al., 1979) 
and dialysis (Hovmöller et al., 1983).  Adsorption by polystyrene beads yielded 2D 
crystals while dialysis led to the growth of stacked, multilamellar crystals.  But it should 
be noted that the dialysis method was easier to control because the low CMC of TX-100 
led to slower detergent removal rates and produced crystals up to 20 µm in size.  In the 
second example, photosystem II (PS-II) reaction center, solubilized in dodecyl maltoside 
and reconstituted in buffer containing 200 mM MgCl2 and 1.5% taurine yielded stacked 
2D crystals (Dekker et al., 1990, Boekema et al., 1990).  This may be due to the 
increased ionic strength of the buffer, or because taurine has ampiphilic properties, 
supporting 2D crystal formation (Dekker et al., 1990 and Boekema et al., 1990).  Finally, 
Ca+2 –ATPase formed stacked 2D crystals at a molar LPR of 25 (Figure 3.7).  These thin 
3D crystals measured several µm in diameter and contained stacked 2D crystals in 
register.  The edge of stacked layers can be seen at the arrowheads.  Stacking could be a 
result of the large soluble domains of Ca+2 –ATPase, which would increase the 





Figure 3.7.  Stacked 2D crystals of Ca+2 –ATPase.  Thin 3D crystals of Ca+2 –ATPase 
obtained at a molar LPR of 25.  Edges of 2D crystals can be seen at the arrowheads.  
Scale bar = 0.1µm (Stokes and Green, 1990). 
 
 
 The formation of mosaic 2D crystals ~100 nm in size, after only 3 days in dialysis 
was surprising (Figure 3.8).  Stacked sheets 0.1 – 2 µm in size were observed in most 
post-dialysis samples and even one sample contained sheets > 10 µm in the longest 
dimension (Figure 3.9).  The rate of detergent removal is dependent on the CMC of the 
individual detergent used.  TX-100 is a low CMC detergent and Na-DOC is a high CMC 
detergent.  The Na-DOC, which has a small micellar weight of ~2,000 Da, is most likely 
dialyzed out of the protein solution quickly.  This leaves TX-100, which has a large 
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micellar weight of ~90,000 Da to remain in the dialysis membrane with the protein in 
solution.  One possible explanation for crystal formation in such short dialysis time is that 
a large portion, but not in its entirety, of TX-100 is already dialyzed out of solution in 4 
days, observed by lab member (unpublished observation from Matthew Johnson).  
Overall, most studies have found that removal of Triton X-100 required 7 – 21 days 
































Figure 3.8.  Stacked 2D crystals of hLTC4S WT after 3 days in dialysis.  The formation 




Figure 3.8.  Stacked 2D crystals of hLTC4S W  t  3 days in dialysis.  The formation 
of stacked 2D crystals, at a molar LPR of 15 after only 3 days in dialysis was unexpected.  
The rate of detergent removal by dialysis is determined by detergent CMC, and thus the 
removal of low CMC TX-100 should be slow, although membranes were still obtained at 
this time point.  a) Low-magnification micrograph of negatively stained hLTC4S.  Sheets 
0.1 – 2 µm in width were observed.  b) High-magnification micrograph of boxed area in 
a).  Mosaic 2D crystalline lattice is visible, at least 100 nm in size.  FFT of boxed area 
(red) inset.  








Figure 3.9.  Large stacked sheets obtained after 3 days in dialysis.  A large sheet, > 10 
µm in the longest dimension, was observed after only 3 days in dialysis.  The protein, at 
0.22 mg/mL concentration, was reconstituted at LPR 15.  a) Low-mag micrograph of 
negatively stained hLTC4S.  Large, mostly continuous sheet measured at least 10 µm, in 
the longest direction.  b)  Smaller sheets, ~0.25 µm, are seen stacked upon the larger 10 
µm sheet.  c)  There are apparent areas of non-stacking, aka unilamellar 2D sheet.  Within 
this unilamellar sheet, a visible 2D lattice is not observed, but upon closer inspection an 







Figure 3.9.  Large stacked sheets obtained after 3 days in dialysis.  A large sheet >10 µm 
in the longest direction was observed after only 3 days in dialysis.  The protein was 
purified to 0.22 mg/mL concentration.  Reconstitution occurred at LPR 15.  a) Low-mag 
micrograph of negatively stained hLTC4S.  b) Smaller sheets ~0.25 µm are seen stacked 
upon the larger 10 µm sheet.  c) There are visibly apparent areas of single, unilamellar 2D 
sheets.  Within unilamellar sheets, a visible 2D lattice is hardly ever observed.  FFT 







Unstacked 2D crystals 
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2D crystals of hLTC4S mutant R104A  
 Based on the mostly successful reproduction of methods to crystallize hLTC4S 
WT (Schmidt-Krey et al., 2004 and Zhao et al., 2010), 2D crystallization trials of mutant 
R104A were performed following these previously established methods.  2D crystal 
growth followed similar patterns as was observed for WT (Table 3.3).  R104A mutant 
was reconstituted into a lipid bilayer and formed stacked 2D crystals, similar to that seen 
for WT at LPR 15 (Figure 3.10).  Encouragingly, minimally stacked sheets were also 
observed (Figure 3.11).  FFT analysis suggests the presence of crystals, indicated by the 
weak spots observed (Figure 3.11b inset).  These near-single layered crystals are ideal for 
further study by cryo-EM as these membrane morphologies are usually highly ordered 
under cryo conditions.  
 
Table 3.3.  2D crystallization parameters of hLTC4S mutant R104A.  Variation of two 
conditions (LPR and time in dialysis) yielded substantially different results.  The table 















5 E2 0.213 0 0 8 Aggregated protein 
5 E2 0.213 5 0.07 8 Aggregated protein 
5 E2 0.213 10 0.135 8 Sheets; weak spots 
5 E2 0.213 15 0.20 8 Sheets; weak spots 
5 E4 0.462 0 0 8 Aggregated protein 
5 E4 0.462 5 0.07 8 Aggregated protein 
5 E4 0.462 10 0.135 8 Stacked sheets; no spots 






Figure 3.10.  2D stacked crystals of hLTC4S mutant R104A.  At an LPR of 15, stacked 
2D crystals of mutant R104A (0.21 mg/mL) were observed.  a)  Low-mag micrograph of 
negatively stained hLTC4S mutant R104A.  Stacked sheets, 0.2 – 0.5 µm, observed. b) 
and c)  High-mag micrograph of boxed areas in a) along with FFT (inset) of boxed      






Figure . .   t cked crystals of hLTC4S mutant R104A.  At a molar LPR of 15 
stacked 2D crystals of mutant R104A, at a concentration of 0.21 mg/mL, were grown.    
a) Low-magnification micrograph of negatively stained hLTC4S mutant R104A.  Stacked 
sheets, 0.2 – 0.5 µm observed.  b) and c) High-magnification micrograph of boxed areas 
in a) along with FFT analysis (inset) of boxed red area.  Scale bar = 0.5 µm. 
 
 
Stacked 2D crystals 





















Figure 3.11.  2D crystal of hLTC4S mutant R104A.  At an LPR of 15, growth of 
unilamellar 2D crystals of mutant R104A were observed.  a) Low-magnification 
micrograph of negatively stained hLTC4S mutant R104A.  Stacked sheets 0.2 – 0.7 µm in 
length were seen.  b) and c) high-magnification micrograph of boxed areas in a) along 












Compared to previously reported data of hTLC4S WT, which formed well-
ordered two-dimensional crystals at low LPRs, (Schmidt-Krey et al., 2004 and Zhao et 
al., 2010) hLTC4S WT and mutant R104A is observed to crystallize at relatively high 
LPR values using a modified purification protocol.  This may be due to efficient 
delipidation and removal of co-purified lipids during purification, thus requiring a larger 
amount of lipid for successful reconstitution.  The identity of co-purified lipids can be 
assessed using 2D thin layer chromatography (TLC) where lipid molecules can be 
identified by comparison to commercially available pure lipid compounds (Christie, 
1982).  The presence of any remaining lipid molecules attached to hLTC4S might suggest 
their importance in structure and function of the enzyme.  Identification of any co-
purified lipids would provide insight into the degree of delipidation that was achieved 
after purification, and also would help to determine the amount of exogenous lipid that 
must be added for reconstitution. 
 As mentioned earlier, ionic strength plays a role in 2D crystallization trials.  
Increased ionic strength is characteristic of 3D crystallization trials, acting as a 
precipitant to increase hydrophilic interactions between the soluble domains of MPs.  
Small 2D crystals of LHC-II were obtained by dialysis against 200 mM KCl (Kühlbrandt, 
1984), which is a high enough concentration of monovalent ions to charge surface amino 
acids and induce 2D crystal stacking (Kühlbrandt, 1992).  hLTC4S was crystallized by 
dialysis against 50 mM KCl, which is typical for many MP 2D crystallization trials.  
Ionic strength may play a factor in the stacking of 2D crystals, as mono- and divalent 
cations screen surface charges allowing stacking to occur via non-polar interactions 
(Abeyrathne et al., 2010).  Another possible explanation for crystal stacking is the 
presence of α-helix V, which protrudes out of the membrane (Figure 3.2) (Zhao et al., 
2010).  Also, a C-terminal His6-tag is attached to the end of helix V, which may present 
additional interactions between 2D membranes.  If the fifth helix is to blame for crystal 
stacking it may be removed as it does not contain the amino acid residues critical for 
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substrate binding, although helix V may still be important for enzyme structure and 
function.  Enzymatic activity of hLTC4S, with removed helix V, should be confirmed 
prior to any crystallization attempts. 
 Upon the determination of successful conditions for 2D crystal formation with 
negative stain, the next step towards the 3D structure determination is electron cryo-
microscopy of frozen-hydrated specimen.  With this technique 2D crystals are left 
unstained and frozen in a layer of vitrified buffer that helps preserve the native structure 
of the MP for structure analysis.  Negatively stained 2D crystals are limited in resolution 
by the grain size of the heavy metal stain.  Frozen-hydrated specimens can produce 
greater details of the architecture of the enzyme because there is no stain to limit the 



















 Parameters for the 2D crystallization of hLTC4S mutant R104A, including LPR 
and time in dialysis variations, were investigated, based on previously published methods 
on the WT enzyme.  Stacks and single layers of 2D sheets were observed after 3 – 8 days 
in dialysis at relatively high LPR values (LPR = 15), most likely due to the efficient 
removal of co-purified lipids.  Fine-tuning of LPR values needs to be further investigated 
with focus on lowering LPR values to obtain well-ordered and large 2D crystals.  Future 
directions for the R104A mutant enzyme include removal of helix 5, which protrudes into 
the solvent, and may be the cause of 2D crystal stacking. 
Stacked 2D crystals are not desired for image processing and data collection by 
transmission electron microscopy, as tilting samples of thin, stacked crystals will not 
provide useful 3D data.  Unstacked and large crystals will provide increasing amounts of 
structural detail. The unstacked crystals of mutant R104A can be used for future cryo-EM 
studies, because FFT analysis of negatively stained are limited in resolution due to stain 
grain size.  Cryo-EM of these samples will usually reveal that these samples are highly 
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